MYPS Form 144: Joel Agena plans small 20K-share sale on 6/25/25
Rhea-AI Filing Summary
PLAYSTUDIOS, Inc. (NASDAQ: MYPS) – Form 144 filing overview
The filing discloses that Joel Agena intends to sell 20,490 Class A common shares on or about 06/25/2025 through Fidelity Brokerage Services on the NASDAQ market. Based on the indicated market price, the proposed sale is valued at $28,016.62. The issuer’s reported shares outstanding total 108,626,198, so the new sale represents roughly 0.02 % of the public float.
The shares were acquired via restricted-stock vesting on 05/15/2023 as compensation. No non-cash consideration was involved.
Prior insider activity (past three months)
- Six sales between 06/16/2025 and 06/24/2025, each for approximately 20,490–20,491 shares.
- Total shares sold: 122,941.
- Total gross proceeds reported: $172,877.80.
The filer affirms that he is unaware of any undisclosed material adverse information about PLAYSTUDIOS and acknowledges the penalties for misstatements under 18 U.S.C. 1001.
Key takeaways for investors
- Continued insider selling trend, though volumes are immaterial relative to total shares outstanding.
- No information on the filer’s remaining ownership or on company fundamentals was provided.
Positive
- None.
Negative
- Insider Joel Agena has filed to sell an additional 20,490 MYPS shares, following six prior sales totaling 122,941 shares within the last week.
Insights
TL;DR: Routine Form 144; small volume insider sale, limited financial impact, mild negative sentiment.
This notice covers 20,490 shares worth $28k—an immaterial 0.02 % of the 108.6 million shares outstanding. While the dollar amount is negligible, it extends a pattern of six similar sales over the prior week, bringing recent insider dispositions to 122,941 shares. Such sequential selling can weigh modestly on market sentiment, but the scale does not meaningfully alter PLAYSTUDIOS’ capital structure or liquidity. No valuation metrics or company performance data accompany the filing, so the transaction appears purely administrative and compensation-driven.
TL;DR: Insider continues planned sales; governance disclosure compliant, impact neutral.
The Form 144 satisfies SEC disclosure rules, listing acquisition via restricted-stock vesting and confirming lack of undisclosed adverse information. The filer’s clustering of seven sales within ten days suggests execution under a systematic program but remains well below the 1 % Rule 144 volume limit. From a governance perspective, transparency is adequate and no red flags—such as Rule 10b5-1 plan dates or related-party transactions—are cited. Given the tiny float percentage, I classify the filing as informational rather than impactful.